Dow Chemical won US regulatory approval on Friday for its deal to buy Rohm and Haas, leaving it to decide whether to attempt to cancel, renegotiate or complete the deal despite the collapse of a joint venture that was meant to fund it.
The two companies were deep in discussions late on Friday over potentially pushing back the deadline by which Dow was supposed to close the deal, currently set for Tuesday night.

M&A 

